IBDEI2KZ ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,41190,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41190,1,3,0)
;;=3^DM Type 1 w/ Diab Autonomic Polyneuropathy
;;^UTILITY(U,$J,358.3,41190,1,4,0)
;;=4^E10.43
;;^UTILITY(U,$J,358.3,41190,2)
;;=^5002607
;;^UTILITY(U,$J,358.3,41191,0)
;;=E10.44^^152^2029^1
;;^UTILITY(U,$J,358.3,41191,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41191,1,3,0)
;;=3^DM Type 1 w/ Diab Amyotrophy
;;^UTILITY(U,$J,358.3,41191,1,4,0)
;;=4^E10.44
;;^UTILITY(U,$J,358.3,41191,2)
;;=^5002608
;;^UTILITY(U,$J,358.3,41192,0)
;;=E10.49^^152^2029^25
;;^UTILITY(U,$J,358.3,41192,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41192,1,3,0)
;;=3^DM Type 1 w/ Oth Diab Neurological Compl
;;^UTILITY(U,$J,358.3,41192,1,4,0)
;;=4^E10.49
;;^UTILITY(U,$J,358.3,41192,2)
;;=^5002609
;;^UTILITY(U,$J,358.3,41193,0)
;;=E10.59^^152^2029^22
;;^UTILITY(U,$J,358.3,41193,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41193,1,3,0)
;;=3^DM Type 1 w/ Oth Circulatory Compl
;;^UTILITY(U,$J,358.3,41193,1,4,0)
;;=4^E10.59
;;^UTILITY(U,$J,358.3,41193,2)
;;=^5002612
;;^UTILITY(U,$J,358.3,41194,0)
;;=E10.610^^152^2029^9
;;^UTILITY(U,$J,358.3,41194,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41194,1,3,0)
;;=3^DM Type 1 w/ Diab Neuropathic Arthropathy
;;^UTILITY(U,$J,358.3,41194,1,4,0)
;;=4^E10.610
;;^UTILITY(U,$J,358.3,41194,2)
;;=^5002613
;;^UTILITY(U,$J,358.3,41195,0)
;;=E10.618^^152^2029^23
;;^UTILITY(U,$J,358.3,41195,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41195,1,3,0)
;;=3^DM Type 1 w/ Oth Diab Arthropathy
;;^UTILITY(U,$J,358.3,41195,1,4,0)
;;=4^E10.618
;;^UTILITY(U,$J,358.3,41195,2)
;;=^5002614
;;^UTILITY(U,$J,358.3,41196,0)
;;=E10.630^^152^2029^30
;;^UTILITY(U,$J,358.3,41196,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41196,1,3,0)
;;=3^DM Type 1 w/ Peridontal Disease
;;^UTILITY(U,$J,358.3,41196,1,4,0)
;;=4^E10.630
;;^UTILITY(U,$J,358.3,41196,2)
;;=^5002619
;;^UTILITY(U,$J,358.3,41197,0)
;;=E10.638^^152^2029^27
;;^UTILITY(U,$J,358.3,41197,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41197,1,3,0)
;;=3^DM Type 1 w/ Oth Oral Compl
;;^UTILITY(U,$J,358.3,41197,1,4,0)
;;=4^E10.638
;;^UTILITY(U,$J,358.3,41197,2)
;;=^5002620
;;^UTILITY(U,$J,358.3,41198,0)
;;=E10.641^^152^2029^15
;;^UTILITY(U,$J,358.3,41198,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41198,1,3,0)
;;=3^DM Type 1 w/ Hypoglycemia w/ Coma
;;^UTILITY(U,$J,358.3,41198,1,4,0)
;;=4^E10.641
;;^UTILITY(U,$J,358.3,41198,2)
;;=^5002621
;;^UTILITY(U,$J,358.3,41199,0)
;;=E10.649^^152^2029^16
;;^UTILITY(U,$J,358.3,41199,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41199,1,3,0)
;;=3^DM Type 1 w/ Hypoglycemia w/o Coma
;;^UTILITY(U,$J,358.3,41199,1,4,0)
;;=4^E10.649
;;^UTILITY(U,$J,358.3,41199,2)
;;=^5002622
;;^UTILITY(U,$J,358.3,41200,0)
;;=E10.65^^152^2029^14
;;^UTILITY(U,$J,358.3,41200,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41200,1,3,0)
;;=3^DM Type 1 w/ Hyperglycemia
;;^UTILITY(U,$J,358.3,41200,1,4,0)
;;=4^E10.65
;;^UTILITY(U,$J,358.3,41200,2)
;;=^5002623
;;^UTILITY(U,$J,358.3,41201,0)
;;=E10.69^^152^2029^29
;;^UTILITY(U,$J,358.3,41201,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41201,1,3,0)
;;=3^DM Type 1 w/ Oth Spec Compl
;;^UTILITY(U,$J,358.3,41201,1,4,0)
;;=4^E10.69
;;^UTILITY(U,$J,358.3,41201,2)
;;=^5002624
;;^UTILITY(U,$J,358.3,41202,0)
;;=E10.8^^152^2029^33
;;^UTILITY(U,$J,358.3,41202,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2KZ 3775 printed Apr 09, 2024@21:53:04 Page 2
IBDEI2KZ ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,41190,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,41190,1,3,0)
+4 ;;=3^DM Type 1 w/ Diab Autonomic Polyneuropathy
+5 ;;^UTILITY(U,$J,358.3,41190,1,4,0)
+6 ;;=4^E10.43
+7 ;;^UTILITY(U,$J,358.3,41190,2)
+8 ;;=^5002607
+9 ;;^UTILITY(U,$J,358.3,41191,0)
+10 ;;=E10.44^^152^2029^1
+11 ;;^UTILITY(U,$J,358.3,41191,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,41191,1,3,0)
+14 ;;=3^DM Type 1 w/ Diab Amyotrophy
+15 ;;^UTILITY(U,$J,358.3,41191,1,4,0)
+16 ;;=4^E10.44
+17 ;;^UTILITY(U,$J,358.3,41191,2)
+18 ;;=^5002608
+19 ;;^UTILITY(U,$J,358.3,41192,0)
+20 ;;=E10.49^^152^2029^25
+21 ;;^UTILITY(U,$J,358.3,41192,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,41192,1,3,0)
+24 ;;=3^DM Type 1 w/ Oth Diab Neurological Compl
+25 ;;^UTILITY(U,$J,358.3,41192,1,4,0)
+26 ;;=4^E10.49
+27 ;;^UTILITY(U,$J,358.3,41192,2)
+28 ;;=^5002609
+29 ;;^UTILITY(U,$J,358.3,41193,0)
+30 ;;=E10.59^^152^2029^22
+31 ;;^UTILITY(U,$J,358.3,41193,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,41193,1,3,0)
+34 ;;=3^DM Type 1 w/ Oth Circulatory Compl
+35 ;;^UTILITY(U,$J,358.3,41193,1,4,0)
+36 ;;=4^E10.59
+37 ;;^UTILITY(U,$J,358.3,41193,2)
+38 ;;=^5002612
+39 ;;^UTILITY(U,$J,358.3,41194,0)
+40 ;;=E10.610^^152^2029^9
+41 ;;^UTILITY(U,$J,358.3,41194,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,41194,1,3,0)
+44 ;;=3^DM Type 1 w/ Diab Neuropathic Arthropathy
+45 ;;^UTILITY(U,$J,358.3,41194,1,4,0)
+46 ;;=4^E10.610
+47 ;;^UTILITY(U,$J,358.3,41194,2)
+48 ;;=^5002613
+49 ;;^UTILITY(U,$J,358.3,41195,0)
+50 ;;=E10.618^^152^2029^23
+51 ;;^UTILITY(U,$J,358.3,41195,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,41195,1,3,0)
+54 ;;=3^DM Type 1 w/ Oth Diab Arthropathy
+55 ;;^UTILITY(U,$J,358.3,41195,1,4,0)
+56 ;;=4^E10.618
+57 ;;^UTILITY(U,$J,358.3,41195,2)
+58 ;;=^5002614
+59 ;;^UTILITY(U,$J,358.3,41196,0)
+60 ;;=E10.630^^152^2029^30
+61 ;;^UTILITY(U,$J,358.3,41196,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,41196,1,3,0)
+64 ;;=3^DM Type 1 w/ Peridontal Disease
+65 ;;^UTILITY(U,$J,358.3,41196,1,4,0)
+66 ;;=4^E10.630
+67 ;;^UTILITY(U,$J,358.3,41196,2)
+68 ;;=^5002619
+69 ;;^UTILITY(U,$J,358.3,41197,0)
+70 ;;=E10.638^^152^2029^27
+71 ;;^UTILITY(U,$J,358.3,41197,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,41197,1,3,0)
+74 ;;=3^DM Type 1 w/ Oth Oral Compl
+75 ;;^UTILITY(U,$J,358.3,41197,1,4,0)
+76 ;;=4^E10.638
+77 ;;^UTILITY(U,$J,358.3,41197,2)
+78 ;;=^5002620
+79 ;;^UTILITY(U,$J,358.3,41198,0)
+80 ;;=E10.641^^152^2029^15
+81 ;;^UTILITY(U,$J,358.3,41198,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,41198,1,3,0)
+84 ;;=3^DM Type 1 w/ Hypoglycemia w/ Coma
+85 ;;^UTILITY(U,$J,358.3,41198,1,4,0)
+86 ;;=4^E10.641
+87 ;;^UTILITY(U,$J,358.3,41198,2)
+88 ;;=^5002621
+89 ;;^UTILITY(U,$J,358.3,41199,0)
+90 ;;=E10.649^^152^2029^16
+91 ;;^UTILITY(U,$J,358.3,41199,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,41199,1,3,0)
+94 ;;=3^DM Type 1 w/ Hypoglycemia w/o Coma
+95 ;;^UTILITY(U,$J,358.3,41199,1,4,0)
+96 ;;=4^E10.649
+97 ;;^UTILITY(U,$J,358.3,41199,2)
+98 ;;=^5002622
+99 ;;^UTILITY(U,$J,358.3,41200,0)
+100 ;;=E10.65^^152^2029^14
+101 ;;^UTILITY(U,$J,358.3,41200,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,41200,1,3,0)
+104 ;;=3^DM Type 1 w/ Hyperglycemia
+105 ;;^UTILITY(U,$J,358.3,41200,1,4,0)
+106 ;;=4^E10.65
+107 ;;^UTILITY(U,$J,358.3,41200,2)
+108 ;;=^5002623
+109 ;;^UTILITY(U,$J,358.3,41201,0)
+110 ;;=E10.69^^152^2029^29
+111 ;;^UTILITY(U,$J,358.3,41201,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,41201,1,3,0)
+114 ;;=3^DM Type 1 w/ Oth Spec Compl
+115 ;;^UTILITY(U,$J,358.3,41201,1,4,0)
+116 ;;=4^E10.69
+117 ;;^UTILITY(U,$J,358.3,41201,2)
+118 ;;=^5002624
+119 ;;^UTILITY(U,$J,358.3,41202,0)
+120 ;;=E10.8^^152^2029^33
+121 ;;^UTILITY(U,$J,358.3,41202,1,0)
+122 ;;=^358.31IA^4^2
